Surprisingly, PCSK9 levels were negatively correlated with LDL in the entire cohort.<h4>Conclusions</h4>In this cohort of men, whole-body lipid metabolic rewiring is a feature restricted to the metastatic phase of prostate cancer, suggesting it may play a significant role in the progression toward more aggressive cancer forms. Here, PCSK9 is linked to prostate cancer.